Gender affirming care in Australia encompasses a range of medical, psychological, and social interventions designed to support transgender and gender diverse individuals in aligning their physical characteristics and social presentation with their gender identity. This includes puberty suppression, gender affirming hormone therapy (GAHT), and surgeries for adults, alongside mental health support. Care is delivered through public specialist clinics, private practitioners, and general practice under informed consent models in some settings. While available nationwide via Medicare-subsidised hormones and select surgical rebates, comprehensive national data on recipients remains limited, with services varying by state and territory.

The Rumble Podcast with Café Locked Out’s Michael Gray Griffith, veteran Australian journalist John Stapleton and an early transitioner Mianna can found here. In this conversation on Café Locked Out, Mianna — who transitioned over thirty years ago under a far more rigorous process — offers a lived perspective. As debates continue, Australia’s response will say much about how we balance compassion, evidence, and caution in matters of profound personal and societal consequence.”

A Brief History

Gender affirming care in Australia dates back to the mid-20th century. The first reported Australian sex reassignment surgery occurred in 1956. By the late 1960s, psychiatric assessments and early surgeries were performed in Melbourne at Royal Melbourne Hospital, with Dr Richard Ball leading research and referrals. The Victorian Health Department established a Transsexualism Consultative Clinic in 1968.

Formal clinics emerged in the 1970s. In 1975, the Gender Dysphoria Clinic opened at Melbourne’s Queen Victoria Hospital (later Monash Health Gender Clinic) under Drs Trudy Kennedy and Herbert Bower, offering psychiatric evaluation, hormones, and surgeries. Similar services appeared in Sydney and Adelaide. The Flinders Medical Centre Gender Clinic in South Australia, established around 1979, performed up to six surgeries annually.

South Australia passed the Sexual Reassignment Act 1988, the first Australian legislation enabling legal sex marker changes.

Adult-focused care dominated until the 2010s. The Royal Children’s Hospital (RCH) Melbourne established a dedicated paediatric Gender Service in 2012. Family Court rulings progressively eased barriers: Re Jamie (2013) allowed puberty blockers without court approval in some cases, reportedly the first such judicial ruling in the world, reflecting the activist nature of sections of Australia’s judiciary, and Re Kelvin (2017), which removed the need for court authorisation for stage-two hormones in most adolescent cases.

The Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents, first published by RCH in 2018 (updated to Version 1.4 by 2023), formalised multidisciplinary, affirmative approaches emphasising mental health assessment and family support.

AusPATH (formerly ANZPATH), the peak professional body, endorsed informed consent models for adults and youth care aligned with international standards.

Public funding expanded gradually. Hormones are subsidised via the Pharmaceutical Benefits Scheme (PBS), though some testosterone listings require authority approval. Surgical procedures have historically relied on non-specific Medicare items or private funding, with an ongoing Medical Services Advisory Committee (MSAC) application (1754) under review since 2023–2024 to create dedicated rebates for adult gender affirming surgeries.

Numbers, Trends, and State Breakdown

Australia lacks a single national registry for gender affirming care recipients. The Australian Bureau of Statistics (ABS) 2022 estimates indicate approximately 178,900 people aged 16 and over (about 0.9–1% of the adult population) have a trans experience: 37.5% trans men, 29.3% trans women, and 32.7% non-binary or other. These figures are distributed proportionally across states, with larger populations in New South Wales, Victoria, and Queensland.

National data on GAHT initiations show clear growth. Administrative records indicate initiations rose from 1,118 in 2013 to 5,135 in 2024, with an increasing proportion using testosterone-based regimens and a declining mean age at initiation. Between 2012 and 2024, over 20,000 individuals started oestradiol-based GAHT and nearly 12,000 started testosterone-based GAHT.

Paediatric and adolescent services have seen the sharpest increases, particularly since the mid-2010s, with a shift toward more birth-registered females seeking care. Public gender clinics operate in all states and territories, though data transparency varies.

  • Victoria: The RCH Gender Service (statewide for under-17s) and Monash Health Gender Clinic (from age 16) are major providers. Total clients seen rose from 472 in 2019 to 1,290 in 2023. In the 2022–23 financial year, 154 Victorian patients were prescribed puberty blockers. pmc.ncbi.nlm.nih.gov
  • Queensland: Referrals to the Children’s Health Queensland Gender Service grew from 190 total clients in 2017 to 922 in 2022, reflecting rapid service expansion.
  • New South Wales: The NSW Specialist Trans and Gender Diverse Health Service operates across sites, with significant staff growth (FTE reaching 16.7 by 2023). A new service at Maple Leaf House added 482 ongoing clients by 2023.
  • Other states: Western Australia’s Perth Children’s Hospital Gender Diversity Service, South Australia’s Women’s and Children’s Hospital Gender Diversity Service, and services in Tasmania, the Australian Capital Territory, and the Northern Territory provide care, though smaller in scale. Staff FTE in WA reached 10.2 by 2023.
  • No complete national puberty blocker prescription data exists, but FOI releases confirm hundreds of annual initiations in major clinics. health.gov.au

Trends indicate exponential growth in youth referrals (often 4–5 fold in major clinics over a decade), stabilisation or slight reduction in some jurisdictions post-2023, and greater demand for adult GAHT. Private care and informed consent prescribing supplement public services, particularly for adults.

The Current Debate: Parameters, Players, and Political Consequences

The debate centres on the evidence base for medical interventions—particularly puberty blockers and GAHT—for minors under 18, balanced against mental health support, desistance rates, and long-term outcomes. Key parameters include: the quality of studies on benefits versus risks (bone density, fertility, sexual function, regret/detransition); the role of co-occurring mental health conditions (autism, trauma, eating disorders); the shift in referral demographics (predominantly adolescent females); and whether an affirmative, multidisciplinary model or more exploratory psychological approaches better serves distressed youth.

International reviews, notably the UK’s 2024 Cass Review, highlighted “remarkably weak” evidence for routine puberty suppression outside clinical trials, prompting restrictions in several European countries.

Main players include:

  • Professional and clinical bodies: AusPATH, the RCH Gender Service, and bodies such as the Royal Australian College of Physicians support evidence-informed affirming care within multidisciplinary teams. The National Health and Medical Research Council (NHMRC) is leading a comprehensive review of the Australian Standards of Care, announced in January 2025, with interim advice on puberty blockers expected mid-2026. health.gov.au
  • Advocacy organisations: Groups such as Transcend Australia, Equality Australia, and peer-led services emphasise access, reduced wait times, and lived-experience input.
  • Critics and cautionary voices: Some paediatricians, psychiatrists, and organisations highlight evidence gaps and call for caution, citing European shifts and Australian clinic audits.
  • Governments and regulators: State health departments manage public services; the Therapeutic Goods Administration and MSAC oversee approvals.

Politically, responses differ by jurisdiction. In January 2025, Queensland’s LNP government paused new referrals for puberty blockers and GAHT for under-18s in public services pending review; the ban was extended in December 2025 until at least 2031, pending completion of UK NHS clinical trials.

The Northern Territory government defunded publicly funded puberty blockers and GAHT for children in December 2025. Other states continue services under existing guidelines.

Federally, Labor Health Minister Mark Butler initiated the NHMRC review to ensure “community confidence” in evidence-based care. Medicare rebates for adult surgeries remain under MSAC assessment. These developments have sparked parliamentary motions, legal challenges, and public discourse, with potential implications for service consistency, waitlists, private care demand, and future federal–state alignment.

Ongoing reviews aim to balance individual access with rigorous evidence standards.

As of 2026, gender affirming care continues to evolve through clinical practice, research, and policy adjustment. With national guidelines under review and state-level variations emerging, Australia’s approach reflects broader international scrutiny of the evidence while maintaining services for those who meet clinical criteria. Data collection and long-term outcome studies will likely shape future provision.

The Cafe Locked Out interview with Mianna

Michael Gray Griffith: Recently I was told the story of a young transitioner who had taken her life a few years after transition.

Her or his death did not make the news, at best they might be populating a statistic, eventually.
But Mianna transitioned over thirty years ago and her journey was different.

Society then forced anyone who wanted to transition to jump through numerous hoops with one goal, to make sure they, the transitioner, and the surgical team were all convinced that this was the correct course of action.

Since then, Mianna has play professional golf and travelled the world. It hasn’t always been easy, but then that’s life.

So this is what this discussion is about. Instead of instant affirmation, is it time to offer those with Gender Dysphoria, or those who believe they have it, greater care, since the procedure is profound and almost impossible to reverse.